| SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2 TM Clausen, DR Sandoval, CB Spliid, J Pihl, HR Perrett, CD Painter, ... Cell 183 (4), 1043-1057. e15, 2020 | 1166 | 2020 |
| Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature 586 (7827), 113-119, 2020 | 794 | 2020 |
| SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling L Miorin, T Kehrer, MT Sanchez-Aparicio, K Zhang, P Cohen, RS Patel, ... Proceedings of the National Academy of Sciences 117 (45), 28344-28354, 2020 | 531 | 2020 |
| MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells X Yin, L Riva, Y Pu, L Martin-Sancho, J Kanamune, Y Yamamoto, K Sakai, ... Cell Reports 34 (2), 108628, 2021 | 401 | 2021 |
| Distinct entry mechanisms for non-enveloped and quasi-enveloped hepatitis E virus X Yin, C Ambardekar, Y Lu, Z Feng Journal of virology 90 (8), 4232-4242, 2016 | 263 | 2016 |
| Functional Landscape of SARS-CoV-2 Cellular Restriction L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham, X Yin, D Pratt, ... Molecular Cell, 2021 | 203 | 2021 |
| Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 S Yuan, X Yin, X Meng, JFW Chan, ZW Ye, L Riva, L Pache, CCY Chan, ... Nature 593 (7859), 418-423, 2021 | 201 | 2021 |
| Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection X Yin, D Ying, S Lhomme, Z Tang, CM Walker, N Xia, Z Zheng, Z Feng Proceedings of the National Academy of Sciences 115 (18), 4773-4778, 2018 | 171 | 2018 |
| Hepatitis E virus persists in the presence of a type III interferon response X Yin, X Li, C Ambardekar, Z Hu, S Lhomme, Z Feng PLoS pathogens 13 (5), e1006417, 2017 | 95 | 2017 |
| A large-scale drug repositioning survey for SARS-CoV-2 antivirals L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, ... BioRxiv, 2020.04. 16.044016, 2020 | 93 | 2020 |
| Role of envelopment in the HEV life cycle X Yin, X Li, Z Feng Viruses 8 (8), 229, 2016 | 87 | 2016 |
| Sensor sensibility—HIV-1 and the innate immune response X Yin, S Langer, Z Zhang, KM Herbert, S Yoh, R König, SK Chanda Cells 9 (1), 254, 2020 | 74 | 2020 |
| mRNA vaccine development for emerging animal and zoonotic diseases T Le, C Sun, J Chang, G Zhang, X Yin Viruses 14 (2), 401, 2022 | 72 | 2022 |
| Sofosbuvir protects human brain organoids against SARS-CoV-2 P Mesci, A Macia, A Saleh, L Martin-Sancho, X Yin, C Snethlage, ... BioRxiv, 2020.05. 30.125856, 2020 | 67 | 2020 |
| Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein X Yin, Z Hu, Q Gu, X Wu, YH Zheng, P Wei, X Wang Journal of virology 88 (2), 1259–1270, 2014 | 52 | 2014 |
| Molecular characterization and phylogenetic analysis of transmissible gastroenteritis virus HX strain isolated from China X Hu, N Li, Z Tian, X Yin, L Qu, J Qu BMC veterinary research 11, 1-7, 2015 | 48 | 2015 |
| Hepatitis E virus entry X Yin, Z Feng Viruses 11 (10), 883, 2019 | 46 | 2019 |
| Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA SM Yoh, JI Mamede, D Lau, N Ahn, MT Sánchez-Aparicio, J Temple, ... Molecular cell 82 (15), 2871-2884. e6, 2022 | 37 | 2022 |
| Cell entry and release of quasi-enveloped human hepatitis viruses A Das, EE Rivera-Serrano, X Yin, CM Walker, Z Feng, SM Lemon Nature Reviews Microbiology 21 (9), 573-589, 2023 | 34 | 2023 |
| Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies Q He, F Zhang, J Shu, S Li, Z Liang, M Du, X Liu, T Liu, M Li, X Yin, Q Pan, ... Hepatology 76 (3), 788-802, 2022 | 34 | 2022 |
Zongdi FengAssociate Professor, Ohio State University/Nationwide Children's Hospital確認したメール アドレス: nationwidechildrens.org